Abstract

BRCA2 and its interactors are required for meiotic homologous recombination (HR) and fertility. Loss of HSF2BP, a BRCA2 interactor, disrupts HR during spermatogenesis. We test the model postulating that HSF2BP localizes BRCA2 to meiotic HR sites, by solving the crystal structure of the BRCA2 fragment in complex with dimeric armadillo domain (ARM) of HSF2BP and disrupting this interaction in a mouse model. This reveals a repeated 23 amino acid motif in BRCA2, each binding the same conserved surface of one ARM domain. In the complex, two BRCA2 fragments hold together two ARM dimers, through a large interface responsible for the nanomolar affinity — the strongest interaction involving BRCA2 measured so far. Deleting exon 12, encoding the first repeat, from mBrca2 disrupts BRCA2 binding to HSF2BP, but does not phenocopy HSF2BP loss. Thus, results herein suggest that the high-affinity oligomerization-inducing BRCA2-HSF2BP interaction is not required for RAD51 and DMC1 recombinase localization in meiotic HR.

BRCA2 and its interactor HSF2BP are required for meiotic recombination. Here, the authors define the interaction structurally, revealing that a repeat in BRCA2 binds two HSF2BP units, increasing the affinity. This region is, however, not essential for mouse meiosis.

Details

Title
BRCA2 binding through a cryptic repeated motif to HSF2BP oligomers does not impact meiotic recombination
Author
Ghouil Rania 1 ; Miron Simona 1 ; Koornneef Lieke 2   VIAFID ORCID Logo  ; Veerman Jasper 3   VIAFID ORCID Logo  ; Paul, Maarten W 3   VIAFID ORCID Logo  ; Le, Du Marie-Hélène 1 ; Sleddens-Linkels Esther 4 ; van Rossum-Fikkert Sari E 5 ; van Loon Yvette 3 ; Felipe-Medina, Natalia 6 ; Pendas, Alberto M 6   VIAFID ORCID Logo  ; Maas, Alex 7 ; Essers Jeroen 8 ; Legrand, Pierre 9   VIAFID ORCID Logo  ; Baarends, Willy M 4   VIAFID ORCID Logo  ; Kanaar Roland 3 ; Zinn-Justin, Sophie 1 ; Zelensky, Alex N 3   VIAFID ORCID Logo 

 CEA, CNRS, Uni Paris-Sud, Uni Paris-Saclay, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France (GRID:grid.457334.2) 
 Erasmus University Medical Center, Department of Developmental Biology, Oncode Institute, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X) 
 Erasmus University Medical Center, Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X) 
 Erasmus University Medical Center, Department of Developmental Biology, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X) 
 Erasmus University Medical Center, Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X); Erasmus University Medical Center, Department of Radiation Oncology, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X) 
 Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca), Molecular Mechanisms Program, Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817) 
 Erasmus University Medical Center, Department of Cell Biology, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X) 
 Erasmus University Medical Center, Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X); Erasmus University Medical Center, Department of Radiation Oncology, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X); Erasmus University Medical Center, Department of Vascular Surgery, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X) 
 Synchrotron SOLEIL, L’Orme des Merisiers, Gif-sur-Yvette, France (GRID:grid.426328.9) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2556149362
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.